Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? - Wikidata - wikimedia - TriplyDB

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

http://www.wikidata.org/entity/Q39201543

about

Umeclidinium for the treatment of uncontrolled asthma.Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.Eosinophils: The unsung heroes in cancer?Human eosinophils and mast cells: Birds of a feather flock together.

P2860

Q38838764-DE534213-C38E-4158-82A2-9EC1B64DD40A Q41098587-9A9019DF-DCC3-498E-896A-DF188403B6B9 Q47225787-016343E0-580E-4AF1-BB9B-451E08338148 Q50068947-2B3F8023-8F74-4F22-A84C-0EC2BDDA4151

P2860

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

http://www.wikidata.org/entity/Q39201543

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@en

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@nl

type

label

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@en

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@nl

prefLabel

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@en

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@nl

P1433

Q39201543-82E53946-F3B8-4BEE-BE4F-57F234713A3B

P1476

Q39201543-B2F8398D-AD79-420A-BA8E-8781479D547D

P2093

Q39201543-0E78A42A-BA78-4C3A-9244-FF0893E9C481

Q39201543-F33F1D7D-EDF4-48A1-8043-324446A8AD93

P2860

Q39201543-00651240-D338-4B07-A1BD-076162C13B90

Q39201543-161D8959-A344-45E6-9AD7-5319E2986F0D

Q39201543-16FB6EC1-21BF-424E-8796-78E2F4341E60

Q39201543-1A40659C-C2DB-448B-AF6F-824EA1B8B296

Q39201543-24A9EBAE-537E-4998-8221-B53F2960DE50

Q39201543-28E8672C-80EA-437E-90E8-A39B9E6BB383

Q39201543-2A4DB093-010C-4CE5-AF24-81E3AD4D1740

Q39201543-32F47784-3530-4C42-8E31-C135CE77288E

Q39201543-3A79984C-0E0A-45F5-8AF2-A3E00DCEC9A3

Q39201543-3EA6DC00-976A-43E0-8205-A839E560FFE3

P304

Q39201543-7D580E47-8220-47B6-8F4A-E779C22E7BE9

P31

Q39201543-863A8687-DB6E-4705-B57F-0C9555D24A5D

P356

Q39201543-3B26B9DE-E5F5-4292-94ED-7FF3CA849CDE

P478

Q39201543-AA640295-6324-419A-B156-549BCE570834

P50

Q39201543-0C39DEDF-3992-4C63-BA4F-AAAB96E6CC49

Q39201543-45049246-5AE4-4C9C-B672-385A4B2B8A02

Q39201543-5E7FDA02-676A-4BE5-933E-A819ACCA99F4

Q39201543-7473CC30-F1A9-459D-97C1-CEA25D0142DB

P577

Q39201543-4A8F315C-107B-48AB-B60A-E8F8E20828A5

P698

Q39201543-66701422-5E5A-491B-936D-610976E7F9B1

P921

Q39201543-340BD4EC-F76F-4C49-BED7-74BA5D0102BD

P932

Q39201543-26E1A83D-1C24-45DF-BD7C-00E572ECFB1F

P356

FIMMU.2017.00242

P1433

Frontiers in Immunology

P1476

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?

@en

P2093

Gilda Varricchi

http://www.w3.org/2001/XMLSchema#string

Stefania Loffredo

http://www.w3.org/2001/XMLSchema#string

P2860

Asthma phenotypes and endotypes: an evolving paradigm for classification

Structural basis of interleukin-5 dimer recognition by its α receptor

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs

Personalized Medicine in Allergy

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma

Reslizumab for Poorly Controlled, Eosinophilic Asthma

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice.

Economic burden of asthma: a systematic review

P304

242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.00242

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Matteo Ferrando

Giorgio Walter Canonica

Gianenrico Senna

P577

2017-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28344579

http://www.w3.org/2001/XMLSchema#string

P921

P932

5344894

http://www.w3.org/2001/XMLSchema#string